Jolt Health Inc. (JOLT) | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
Jolt Health Inc.

BRIEF

published on 07/26/2024 at 23:05, 3 months 25 days ago

Jolt Health Inc. Announces Correction in Financing Details

Biotechnology Press Release Correction Healthcare Investment Jolt Health Financing Update
PRESS RELEASE

published on 07/26/2024 at 23:00, 3 months 25 days ago

Jolt Health Inc. Financing Update
Jolt Health Inc. corrects an error in its press release, stating it will issue 83,333,333 units at $0.006 per unit, not 583,333,333 units. The company focuses on healthcare, biotechnology, and artificial intelligence

Biotechnology Healthcare Press Release Correction Jolt Health Inc.
BRIEF

published on 07/25/2024 at 23:05, 3 months 26 days ago

Jolt Health Inc. Announces Financing

Private Placement Common Shares Warrants Working Capital Financing
PRESS RELEASE

published on 07/25/2024 at 23:00, 3 months 26 days ago

Jolt Health Inc. Announces Financing
Jolt Health Inc. announces a $500,000 non-brokered private placement offering. The company plans to issue units at $0.006 per unit for working capital. Insiders expected to participate

Private Placement Working Capital Financing Insiders Jolt Health Inc.
BRIEF

published on 06/10/2024 at 22:55, 5 months 10 days ago

Jolt Health Inc. Terminates Acquisition Agreement and Shifts Focus to AI Opportunities

Acquisition Technology AI Healthcare Jolt Health
PRESS RELEASE

published on 06/10/2024 at 22:50, 5 months 10 days ago

Jolt Health Inc. Terminates Acquisition Agreement and Shifts Focus to AI Opportunities
Jolt Health Inc. terminates acquisition of transdermal delivery technology for chloroquine and hydroxychloroquine, focusing on AI opportunities in healthcare and biotechnology. CEO Gerald Tritt emphasizes value of AI technology and growth initiatives

Biotechnology AI Technology Healthcare Jolt Health Inc. Gerald Tritt
BRIEF

published on 05/06/2024 at 23:30, 6 months 14 days ago

Jolt Health Inc. Acquires Revolutionary HCQ Transdermal Patch Technology

FDA Approval Transdermal Patch Technology Jolt Health Inc. Hydroxychloroquine Biotechnology Assets
PRESS RELEASE

published on 05/06/2024 at 23:25, 6 months 14 days ago

Jolt Health To Acquire HCQ Transdermal Patch Technology
Jolt Health Inc. acquires intellectual property for transdermal delivery tech of HCQ & CQ to address underserved lupus, rheumatoid arthritis, and malaria markets worth $6B by 2027*

Jolt Health Inc. Hydroxychloroquine Transdermal Delivery Technology Chloroquine FDA Approved
BRIEF

published on 03/27/2024 at 21:55, 7 months 24 days ago

Jolt Health Inc. Announces Closing of Financing

Private Placement Working Capital Financing Debt Repayment Jolt Health Inc
PRESS RELEASE

published on 03/27/2024 at 21:50, 7 months 24 days ago

Jolt Health Inc. Announces Closing of Financing
Jolt Health Inc. closes non-brokered private placement of 50,000,000 units at $0.01 per unit for gross proceeds of $500,000. Proceeds to be used for working capital and debt repayment. Insider participation and warrant details disclosed

Private Placement Working Capital Non-brokered Common Share Jolt Health Inc.

Accesswire

Published on 11/21/2024 at 10:03, 49 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 52 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 52 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 17 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 27 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 22 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 47 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 50 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 52 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 52 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 54 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 32 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 7 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 7 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE